Skip to main content

Freshworks Unifies Global Sales Organization to Accelerate Growth

Promotes Chief of Global Field Operations Ian Tickle to Chief Revenue Officer SAN MATEO, Calif., March 05, 2026 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH), the leading provider of uncomplicated AI-powered software, today announced leadership changes under its CEO and President Dennis Woodside. With employee experience at the forefront of our strategy and revenue growth plans, the Company has decided to unify its global sales organization under its current Chief of Global Field Operations, Ian Tickle. “By unifying our sales organization under a single leader, we believe we can accelerate growth and deliver exceptional value to our global customer base,” said CEO Dennis Woodside. “Ian has a proven track record and played a significant role in Freshworks outperforming for the last five consecutive quarters, underscoring his...

Continue reading

MannKind Announces Settlement of Convertible Senior Notes

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 05, 2026 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) today announced the settlement of the remaining $36.3 million aggregate principal amount of 2.50% convertible senior notes, all of which were tendered for conversion prior to the maturity date of March 1, 2026. The settlement was made on March 4, 2026, with $35.5 million in cash and 569,023 shares of MannKind common stock. About MannKindMannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic...

Continue reading

GalaxyEdge Acquisition Corp. Announces Closing of $100 Million Initial Public Offering

NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) — GalaxyEdge Acquisition Corp (NYSE: GLEDU, the “Company”) announced today that it closed its initial public offering (“IPO”) of 10,000,000 units at an offering price of $10.00 per unit. The underwriters have a 45-day option from the date of the prospectus to purchase up to an additional 1,500,000 units from the Company at the IPO price to cover over-allotments, if any. Each unit consisting of one Class A ordinary share and one right to receive one-fourth (1/4) of one Class A ordinary share upon the consummation of an initial business combination. The units are listed on The New York Stock Exchange (“NYSE”) and began trading under the ticker symbol “GLEDU” on March 4, 2026. Once the securities comprising the units begin separate trading, the ordinary share and rights are expected to be...

Continue reading

Sunrise Realty Trust Expands Revolving Credit Facility to $165 Million with Addition of Customers Bank

WEST PALM BEACH, Fla., March 05, 2026 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced the expansion of its senior secured revolving credit facility (the “Credit Facility”) with the addition of Customers Bank. Customers Bank has committed $25 million to the facility, bringing total committed capital to $165 million. The Credit Facility, originally established with East West Bancorp, Inc. in November 2024, remains expandable to $200 million, subject to certain conditions and additional lender participation. Proceeds from the Credit Facility will be used to finance the Company’s ongoing originations across its target CRE markets, fund future draws and unfunded commitments under existing loans, and manage liquidity...

Continue reading

MediWound Files Annual Report on Form 20-F

MediWound Files Annual Report on Form 20-F YAVNE, Israel, March 5, 2026 — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (the “SEC”) on March 5, 2026. The annual report can be accessed on the SEC’s website at http://www.sec.gov, as well as via the Company’s investor relations website at http://ir.mediwound.com. The Company will provide a hard copy of its annual report on Form 20-F, including its audited financial statements, free of charge, to its shareholders upon request. Request should be directed in writing by email to jeremy@lifesciadvisors.com or by post to MediWound Ltd., 42 Hayarkon St., Yavne 8122745, Israel. About...

Continue reading

Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026

Late-breaking oral presentation to feature primary analysis from KYSA-8 registrational trial in stiff person syndrome (SPS) Oral presentation on updated KYSA-6 Phase 2 data in generalized myasthenia gravis (gMG) EMERYVILLE, Calif., March 05, 2026 (GLOBE NEWSWIRE) — Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today announced multiple abstracts selected for presentation at the American Academy of Neurology (AAN) Annual Meeting, taking place from April 18-22, 2026, in Chicago, IL. “Our presence at AAN marks an important milestone for Kyverna as we build upon miv-cel’s potential to redefine the treatment paradigm in both stiff person syndrome and myasthenia gravis,” said Warner Biddle, Chief Executive Officer of Kyverna Therapeutics....

Continue reading

Methode Electronics Announces Sale of dataMate Business

SOUTHFIELD, Mich., March 05, 2026 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI) today announced the sale of its dataMate copper transceiver business to Bel Fuse Inc.® (NASDAQ: BELFA, BELFB), a leading global manufacturer of products that power, protect, and connect electronic circuits. The divestiture will enable Methode to sharpen the focus on key growth strategies, particularly in the area of power solutions, with a focus on data center business and power delivery and distribution products, anticipating the increasingly demanding requirements of very dense AI computing architectures. “This deal furthers our stated strategy of portfolio refinement and debt reduction while freeing resources for Methode to concentrate on its high-density power delivery products and streamline our facilities footprint,” said Jon DeGaynor,...

Continue reading

Toll Brothers Announces Liberty Ridge Community Coming Soon to Boulder City, Nevada

Liberty Ridge offers stunning homes on expansive home sites in a premier location near Lake Mead BOULDER CITY, Nev., March 05, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest Las Vegas-area community, Liberty Ridge, is coming soon to Boulder City, Nevada. This exclusive community will feature two collections of stunning single-family homes on generous home sites, offering home shoppers a rare opportunity to own a new construction home in charming Boulder City. Site work is underway, and the community is anticipated to open for sale in summer 2026.Overlooking Boulder Creek Golf Club and only 15 minutes from scenic Lake Mead and the mighty Hoover Dam, Liberty Ridge is a community of rarely offered new homes in Boulder City. Two collections of stunning...

Continue reading

DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants

BROSSARD, Quebec, March 05, 2026 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (AI) techniques, announces that it intends to amend the terms of an aggregate amount of $510,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on March 1, 2022, and subsequently amended on March 1, 2025 (pleaser refer to the press release dated February 28, 2025). The amendments are as follows:The amended maturity date set for March 1, 2026, as announced in the press release dated February 28, 2025, is extended to March 1, 2027, The conversion price of the Debentures is amended from $0.38 to...

Continue reading

CoinShares CEO to Participate in Canaccord Genuity Virtual Digital Assets Symposium

5 March 2026 | SAINT HELIER, Jersey | CoinShares International Limited (“CoinShares” or “the Company”) (Nasdaq Stockholm: CS; OTCQX: CNSRF), a leading global asset manager specialising in digital assets, today announced that Jean-Marie Mognetti, Chief Executive Officer and Co-Founder, will participate in a fireside chat at Canaccord Genuity’s 6th Annual Virtual Digital Assets Symposium on 11 March 2026 from 11:30 AM to 11:55 AM ET. CoinShares is the world’s fourth-largest digital asset ETP manager and holds the #1 position in Europe with approximately 34% market share. The Company has been at the forefront of regulated digital asset investment since launching the world’s first Bitcoin ETP in 2015. Event Details:Event: Canaccord Genuity 6th Annual Virtual Digital Assets Symposium Date: 11 March...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.